Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAX8 | Q06710 | 1/20 | 0.69 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.69 |
| ▸ | HPGD | P15428 | 1/20 | 0.67 |
| ▸ | TYMP | P19971 | 3/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.63 |
| ▸ | DPP4 | P27487 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.63 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.63 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.63 |
| ▸ | GAPDH | P04406 | 1/20 | 0.63 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.63 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.63 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.63 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.63 |
| ▸ | STAT6 | P42226 | 1/20 | 0.63 |
| ▸ | PI4KA | P42356 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Inosine SCHEMBL13062153 | 1.00 | PAX8 (0.69) | PAX8P2RX3HPGDTYMPMAPK1 | |
| Inosine SCHEMBL13320592 | 1.00 | PAX8 (0.69) | PAX8P2RX3HPGDTYMPMAPK1 | |
| Inosine SCHEMBL6748953 | 1.00 | PAX8 (0.69) | PAX8P2RX3HPGDTYMPMAPK1 | |
| Inosine SCHEMBL18249508 | 1.00 | PAX8 (0.69) | PAX8P2RX3HPGDTYMPMAPK1 | |
| Inosine SCHEMBL12964365 | 1.00 | PAX8 (0.69) | PAX8P2RX3HPGDTYMPMAPK1 | |
| Inosine SCHEMBL1738548 | 1.00 | PAX8 (0.69) | PAX8P2RX3HPGDTYMPMAPK1 | |
| Inosine SCHEMBL16707275 | 1.00 | PAX8 (0.69) | PAX8P2RX3HPGDTYMPMAPK1 | |
| Inosine SCHEMBL13012212 | 1.00 | PAX8 (0.69) | PAX8P2RX3HPGDTYMPMAPK1 | |
| Inosine SCHEMBL6933022 | 1.00 | PAX8 (0.69) | PAX8P2RX3HPGDTYMPMAPK1 | |
| Inosine SCHEMBL10001664 | 1.00 | PAX8 (0.69) | PAX8P2RX3HPGDTYMPMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4003515-B1 | KLF INDUCED CARDIOMYOGENESIS | VICTOR CHANG CARDIAC RES INSTITUTE (AU) | 2025-10-22 | — | — | EP | claimed |
| EP-3572513-B1 | HIPPO AND DYSTROPHIN COMPLEX SIGNALING IN CARDIOMYOCYTE RENEWAL | BAYLOR COLLEGE MEDICINE (US) | 2025-09-24 | — | — | EP | claimed |
| CN-119630691-A | Method for treating muscular dystrophy | 萨勒普塔医疗公司 | 2025-03-14 | — | — | CN | claimed |
| CN-117321085-A | Compositions and methods for treating skeletal muscle disorders | 耶鲁大学 | 2023-12-29 | — | — | CN | claimed |
| EP-3495472-B1 | RECOMBINANT VIRUS PRODUCTS AND METHODS FOR INHIBITION OF EXPRESSION OF MYOTILIN | NATIONWIDE CHILDRENS HOSPITAL INC (US) | 2023-11-15 | — | — | EP | claimed |
| CN-116134047-A | Systemic delivery of G-inosine expressing adeno-associated viral vectors and treatment of muscular dystrophy | 萨勒普塔医疗公司 | 2023-05-16 | — | — | CN | claimed |
| CN-120400170-A | Adeno-associated viral vector delivery of alpha-inosine and treatment of muscular dystrophy | 全国儿童医院研究所 | 2025-08-01 | — | — | CN | disclosed |
| CN-120400170-A | Adeno-associated viral vector delivery of alpha-inosine and treatment of muscular dystrophy | 全国儿童医院研究所 | 2025-08-01 | — | — | CN | disclosed |
| CN-111902539-B | Heterozygous regulatory element | 吉尼松公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-114945583-B | Adeno-associated viral vector delivery of alpha-inosine and treatment of muscular dystrophy | 全国儿童医院研究所 | 2025-04-29 | — | — | CN | disclosed |
| CN-114945583-B | Adeno-associated viral vector delivery of alpha-inosine and treatment of muscular dystrophy | 全国儿童医院研究所 | 2025-04-29 | — | — | CN | disclosed |
| CN-114945583-B | Adeno-associated viral vector delivery of alpha-inosine and treatment of muscular dystrophy | 全国儿童医院研究所 | 2025-04-29 | — | — | CN | disclosed |
| CN-114641501-B | Anti-VSIG 4 antibodies or antigen binding fragments and uses thereof | Y生物股份有限公司 | 2025-04-18 | — | — | CN | disclosed |
| CN-117545778-A | Novel stable anti-VISTA antibodies | 皮埃尔法布雷医药公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-110770346-B | Polyploid adeno-associated virus vectors and methods of making and using same | 北卡罗来纳-查佩尔山大学 | 2024-01-12 | — | — | CN | disclosed |
| CN-117384964-A | Delivery of beta-inosine and microRNA-29 by adeno-associated viral vectors and treatment of muscular dystrophy | 全国儿童医院研究所 | 2024-01-12 | — | — | CN | disclosed |
| CN-117321085-A | Compositions and methods for treating skeletal muscle disorders | 耶鲁大学 | 2023-12-29 | — | — | CN | disclosed |
| CN-116348149-A | Adeno-associated viral vector delivery for muscular dystrophy | 全国儿童医院研究所 | 2023-06-27 | — | — | CN | disclosed |
| CN-116134047-A | Systemic delivery of G-inosine expressing adeno-associated viral vectors and treatment of muscular dystrophy | 萨勒普塔医疗公司 | 2023-05-16 | — | — | CN | disclosed |
| CN-114641501-A | anti-VSIG 4 antibodies or antigen binding fragments and uses thereof | Y生物股份有限公司 | 2022-06-17 | — | — | CN | disclosed |